(Q39872951)

15 September 2017

Serotype distribution of invasive pneumococcal disease during the first 60 days of life (English)

1 reference

15 September 2017

2

0 references

author name string

Matthias Imöhl

series ordinal

1

1 reference

15 September 2017

Christina Mutscher

series ordinal

3

1 reference

15 September 2017

Ralf René Reinert

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

14 May 2010

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

30

1 reference

15 September 2017

4758-4762

1 reference

Pneumococcus: the first one hundred years.

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Temporal and Geographic Stability of the Serogroup‐Specific Invasive Disease Potential of Streptococcus pneumoniae in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Prospects for prevention of childhood infections by maternal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

7 January 2021

Maternal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

7 January 2021

Maternal immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Increased prevalence of pediatric pneumococcal serotypes in elderly adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Streptococcus pneumoniaeInfections in the Neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vacc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Declining invasive pneumococcal disease mortality in the United States, 1990-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Pneumococcal conjugate vaccines--a European perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

10.1016/J.VACCINE.2010.04.097

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference